Hall & Partners recently announced Abigail Stuart as Global CEO of Hall & Partners Health business. She is based in the company’s London office.
With nearly 20 years of specialist healthcare research experience, Abigail has focused her career on helping pharmaceutical companies develop brand strategy and communications for new and existing brands. Her experience covers a broad range of therapy areas, including respiratory, dermatology, neurology and cardiovascular disease using an array of research methodologies.
She joined Hall & Partners in 1999 to help set up the specialised healthcare division in the London office. Abigail is credited for successfully managing to adapt consumer thinking and creative research techniques for the pharmaceutical industry.
Global CEO, Vanella Jackson said: “Abigail continues to do a phenomenal job – our Health business is thriving and constantly innovating, with the team always delivering outstanding work and new thinking. They manage to stay on top and ahead of industry trends and any potential competitors. We are thrilled to appoint her as Global CEO of our Health business.”
Abigail received a First Class BA Honours Degree in Human Geography from Queen Mary and Westfield College, University of London.
For more information please visit: http://www.hallandpartners.com/ | @HallandPartners